Surgery Ppt Colorectal
Surgery Ppt Colorectal
Surgery Ppt Colorectal
PRESENTATIO
N
COLORECTAL CANCER
Lifestyle
Family
Age and dietary
history
factors
Inflammato
Genetic
ry bowel Polyps
factors
diseases
GENETIC FACTORS
Certain inherited genetic syndromes, such as Lynch syndrome and
familial adenomatous polyposis (FAP), increase the risk of developing
colorectal cancer.
Familial adenomatous polyposis (FAP) accounts for 1% of colorectal
cancer cases.
Hereditary non-polyposis colorectal cancer (HNPCC), sometimes
called Lynch syndrome, accounts for approximately 5% to 10% of all
colorectal cancer cases.
Mutations in specific genes, such as APC and KRAS, are also
associated with an increased risk.
POLYPS
• Benign growths on the inner
wall of the colon and rectum.
They are fairly common in
people over age 50. Some
types of polyps increase a
person's risk of developing
colorectal cancer.
• the risk of malignant change
in benign polyp depend on
many factors including: size,
number of polyp, histological
type
• the risk of cancer
development is more common
in villous type of adenomas
than in tubular type also
presence of epithelial
CLINICAL FEATURES
• TENESMUS
• CONSTIPATIO
• DIARRHEA • BLOOD AND
N
• ANEMIA MUCOUS
• BLEEDING PR
DISCHARGE
PRESENTATION
Patient may
Metastasis
present as an
presentation
emergency case in
includes:
the form of
• Acute intestinal • Jaundice
obstruction • Fistulae
• Perforation • Cough
result in fecal
peritonitis
INVESTIGATIONS
Digital
Rectal Fecal occult Blood &
plainX-ray
Examinatio blood(FOB) electrolytes
n (DRE)
Barium Intrarectal
CT-SCAN MRI
enema USS
Double contrast
barium Enema
CT SCAN
OF COLON
CANCER
ENDOSCOPIES
Colonosco
py
Transanal Excision
Partial Colectomy:
Total Colectomy:
Subtotal Colectomy:
Partial Subtotal
Colectomy: This Colectomy: This
procedure involves Total Colectomy:
procedure involves
the removal of a In cases where the
the removal of a
segment of the entire colon is
significant portion
colon containing affected by the
of the colon along
the tumor along tumor, a total
with the rectum,
with a margin of colectomy may be
but a small
healthy tissue on performed. This
proximal segment
either side of the procedure involves
of the colon is left
tumor. The the removal of the
intact and
remaining ends of entire colon along
connected to the
the colon are then with the rectum.
ileum (small
reconnected. intestine).
PROCTECTOMY
Proctectomy
: Proctectomy • Anterior Resection
involves the • Abdominoperineal
removal of the Resection (APR)
rectum. There
are three • Total Mesorectal
main types of Excision (TME)
proctectomy:
Total Mesorectal
Anterior Abdominoperineal Excision (TME):
Resection (APR):
Resection: This TME is a specialized
This procedure is
procedure is performed when the technique used
performed when tumor is located in the during rectal cancer
the tumor is lower part of the surgery. It involves
rectum or anal canal. the meticulous
located in the
The rectum, anus, and removal of the
upper or middle part of the sigmoid entire layer of tissue
part of the rectum. colon are removed. A surrounding the
The rectum is permanent colostomy rectum
removed, and the is then created, with (mesorectum) to
remaining colon is the end of the colon
ensure complete
attached to an
sutured to the opening (stoma) on
tumor removal and
anal canal. the abdominal wall. reduce the risk of
local recurrence.
Adjuvant
Chemotherapy:
Neoadjuvant
Refers to the use of Chemotherapy:
chemotherapy after
surgical removal of Neoadjuvant
the tumor to kill any chemotherapy is
remaining cancer the use of
CHEMOTHERA cells and reduce the chemotherapy
risk of recurrence. before surgery,
PY recommended for
with the goal of
patients with stage
III and high-risk shrinking the
stage II colorectal tumor and
cancer making it easier
• Fluorouracil (5-FU) to remove
• Oxaliplatin surgically.
• Leucovorin (folinic
acid):
Palliative Chemotherapy:
Palliative chemotherapy is used to
relieve symptoms, control the
growth of the tumor, and improve
overall quality of life in patients
with advanced, metastatic
colorectal cancer.
FOLFOX, FOLFIRI (fluorouracil,
leucovorin, and irinotecan), and
combination therapies with
targeted agents such as
bevacizumab (anti-VEGF) or
cetuximab (anti-EGFR).
Antiangiogenesis therapy:
Starves "the tumor by
disrupting its blood supply This
therapy is given along with
chemotherapy. Bevacizumab
NEW (Avastin).
THERAPY Targeted Therapy: Treatment
designed to target cancer cells
while minimizing damage to
healthy cells.
Cetuximab(Erbitux)
Diet: low in fat, high in fruits and
vegetables and fiber
PROVISIONAL
DIAGNOSIS CAN BE
MADE PAIN INTERMITTENT PAIN
BLEEDING PER RECTUM
FOR 1 MONTH
• DIVERTICULITIS
• ADENOMATOUS POLYP
REFERENCE
• BAILEY AND LOVE SHORT PRACTICE ON SURGERY 27th EDITION
• SABISTON TEXTBOOK OF SURGERY 21st EDITION
• VISHRAM SINGH TEXTBOOK ON ANATOMY
• PICTURE COURTESY
1. GOOGLE IMAGES
2. NETTERS ATLAS